Skip to main content
Caplight Logo









Vaginal Biome Science

Vaginal Biome Science

Private
Portland, OregonHealthcare & Life Scienceshttps://vaginalbiomescience.com/

Last Round

Series A

Sep 27, 2023

Total Funding Raised

$19M

Company Overview

Vaginal Biome Science is a biotechnology company that develops vaginal microbiota-based therapies and diagnostic tools to protect and restore vaginal health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Hardware Sales

AI Layer

Application

Keywords

vaginal microbiomevaginal healthbiomimetic formulationvaginal dysbiosismicrobiome diagnosticsfemtechqPCRprecision medicineclinical researchproduct certificationat-home testinggynecological healthmicrobiome testingwomen's health tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vaginal Biome Science Comparables

Compare Vaginal Biome Science with similar companies based on industry and business-model similarity.

Vaginal Biome Science comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Evvy
78%
Freya Biosciences
78%
Daye
71%

Vaginal Biome Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 27, 2023
SeedJul 14, 2021

Vaginal Biome Science Investors

Notable investors and investment history

Vaginal Biome Science investors
InvestorRounds
Human VenturesSeed
BBG VenturesSeed
General CatalystSeed, Series A
BoxGroupSeed
Left Lane CapitalSeries A
Amboy Street VenturesSeries A
VirtueSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 303% MoM, reaching 395.

  • Mar 12, 2024

    Grew 150% QoQ, from 2 to 5 employees.

Vaginal Biome Science Filings

Explore SEC and related filing metadata, where available.

Vaginal Biome Science filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vaginal Biome Science's valuation, stock price, and market status.

Is Vaginal Biome Science a public or private company?

Vaginal Biome Science is a private company.

What is the current stock price of Vaginal Biome Science?

Vaginal Biome Science is a private company with no public stock price. No recent secondary market data is available.

How much is Vaginal Biome Science worth (valuation)?

Valuation information for Vaginal Biome Science is not publicly available.

Can I buy Vaginal Biome Science stock?

Vaginal Biome Science shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vaginal Biome Science's last funding round?

Vaginal Biome Science's most recent funding round was Series A on September 27, 2023.

Who are the main investors in Vaginal Biome Science?

Key investors in Vaginal Biome Science include Left Lane Capital.

Will Vaginal Biome Science IPO soon?

No public IPO plans have been announced for Vaginal Biome Science.

How can I track Vaginal Biome Science secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vaginal Biome Science's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPortland, Oregon
Employee Range4
Year Founded2021
Last FundingSep 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?